Tag Archives: GILD

Hot Heal Care Stocks To Own For 2019

Facing more than $80,000 in student loan debt, Tiffany Tatafu did what thousands of other student loan borrowers do: She searched for answers on her phone.

The single mother of two had heard that as a public employee, she could be eligible for student loan forgiveness. She’d landed a job as a student support coordinator at Arizona State University after earning a master’s degree in education in 2017.

Tatafu called one of the first listings that came up in her search.

A representative at the company pushed her to sign up for its service, which cost $50 per month for three years on top of her normal student loan payments. They told her it was the only way she’d qualify for forgiveness, Tatafu recalls.

“They definitely made it sound like I had to go through them or I would not be in the program,” Tatafu says. “So they lied.”

Hot Heal Care Stocks To Own For 2019: Gilead Sciences, Inc.(GILD)

Advisors’ Opinion:

  • [By Lee Jackson]

    This stock is trading a very reasonable 10.6 times estimated 2018 earnings. Gilead Sciences Inc. (NASDAQ: GILD) is a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of HIV/AIDS, liver disease, cancer and inflammation. The recent acquisition of KITE allows for entry into the CAR-T space, indicating a renewed focus in oncology.

  • [By Todd Campbell, Keith Speights, and Chuck Saletta]

    It’s not every day that shares in top companies can be bought at a reasonable valuation, so investors ought to pay attention when it happens. For instance, these three Motley Fool contributors believe Gilead Sciences (NASDAQ:GILD), Magellan Health (NASDAQ:MGLN), and Celgene Corp (NASDAQ:CELG) shares represent a unique opportunity to buy leading healthcare companies on sale. Are these stocks a good fit for your portfolio?

  • [By Keith Speights]

    You might be tempted to write off Gilead Sciences (NASDAQ:GILD).

    The once high-flying biotech has lost 45% of its market cap since mid-2015. After the stock climbed more than 20% earlier this year, Gilead lost all of those gains and then some. Sales for the company’s hepatitis C virus (HCV) franchise continue to drop faster than a brick. Gilead’s other drugs can’t generate nearly enough growth to offset the HCV declines.

Hot Heal Care Stocks To Own For 2019: Dynamic Materials Corporation(BOOM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Dmc Global (NASDAQ:BOOM) was downgraded by research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a report issued on Thursday.

  • [By Joseph Griffin]

    Dmc Global (NASDAQ:BOOM) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “DMC Global Inc. is a technology company. Its operating sector consists of industrial infrastructure and oilfield products and services. Industrial infrastructure sector is served by DMC’s NobelClad business is a manufacturer of explosion-welded clad metal plates, which are used to fabricate capital equipment. Oilfield products and services sector is served by DynaEnergetics, is a developer, manufacturer and marketer of advanced explosive components and systems used to perforate oil and gas wells. DMC Global Inc. is based in Boulder, Colorado. “

  • [By Motley Fool Transcribers]

    DMC Global Inc.  (NASDAQ:BOOM)Q4 2018 Earnings Conference CallFeb. 21, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Hot Heal Care Stocks To Own For 2019: CB Financial Services, Inc.(CBFV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CB Financial Services (CBFV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    CB Financial Services Inc (NASDAQ:CBFV)’s share price hit a new 52-week high and low on Wednesday following a dividend announcement from the company. The company traded as low as $34.95 and last traded at $34.40, with a volume of 4600 shares traded. The stock had previously closed at $34.65.

Top Warren Buffett Stocks To Buy Right Now

Investors looking for profits in the healthcare sector had a difficult time in 2017 if they weren’t in biotech. The Health Care SPDR ETF (NYSE: XLV) only gained 13.15% last year, while the S&P 500 climbed 22.5% over the same time period.

But the biotech sector crushed the market, with the SPDR S&P Biotech ETF (NYSE: XBI) returning a market-beating 43.36% in 2017, nearly double the broader S&P 500.

That’s why we’ll show you the three best biotech stocks to buy for 2018.

Despite the exceptional run for biotech stocks in 2017, the broader healthcare sector has been facing a strong headwind over the past few years that scared away some investors.

Drug pricing controversies, increased generic competition for blockbuster drugs, and the recent merger between retail giant CVS Health Corp. (NYSE: CVS) and insurance company Aetna Inc. (NYSE: AET) have weakened returns for shareholders.
In addition, Amazon.com Inc. (Nasdaq: AMZN), Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK.A), and JPMorgan Chase & Co. (NYSE: JPM) announced a joint venture to enter the health insurance industry.

Top Warren Buffett Stocks To Buy Right Now: Castle Brands, Inc.(ROX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Castle Brands (NYSEAMERICAN:ROX) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 6,422,984 shares, a decrease of 5.8% from the April 30th total of 6,815,151 shares. Based on an average daily volume of 169,266 shares, the short-interest ratio is presently 37.9 days. Currently, 7.2% of the company’s stock are sold short.

Top Warren Buffett Stocks To Buy Right Now: Gilead Sciences, Inc.(GILD)

Advisors’ Opinion:

  • [By George Budwell]

    When it comes to biotech stocks, Celgene (NASDAQ:CELG) and Gilead Sciences (NASDAQ:GILD) are easily two of the brightest stars. After all, these two top dogs have generated enormous returns for investors since the start of the biotech bull market back in 2010:

  • [By Keith Speights]

    Gilead Sciences (NASDAQ:GILD), Amgen (NASDAQ:AMGN), and Johnson & Johnson (NYSE:JNJ) rank as the three top biopharmaceutical companies when it comes to cash stockpiles. Here’s what these drugmakers are most likely to do with all that money — and whether or not you should consider investing some of your hard-earned cash to buy their stocks.

  • [By Cory Renauer]

    Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL), and Gilead Sciences Inc. (NASDAQ:GILD) are three top stocks for investing this arena, which could be worth as much as $35 billion annually by 2020. There are plenty of companies with NASH candidates, but these three biotechs rise to the top of the list for some very different reasons.

  • [By Cory Renauer]

    Biotech traders get heaps of attention, but buying promising young drugmakers and holding them for the long term is a far easier way to get rich. Case in point: Spreading $10,000 evenly among shares of Biogen Inc. (NASDAQ:BIIB), Celgene Corporation (NASDAQ:CELG), and Gilead Sciences Inc. (NASDAQ:GILD) around this time in 1998 would have made you a millionaire already. 

  • [By Chris Lange]

    Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest increase slightly to 16.28 million shares from 16.13 million in the previous period. Shares were trading at $67.85, in a 52-week range of $63.76 to $89.54.

  • [By Chris Lange]

    Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest decrease to 17.44 million shares from 18.22 million in the previous period. Shares were trading at $72.72, in a 52-week range of $63.76 to $89.54.

Top Warren Buffett Stocks To Buy Right Now: Ducommun Incorporated(DCO)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    NVIDIA Corporation (NASDAQ: NVDA) is estimated to post quarterly earnings at $1.45 per share on revenue of $2.89 billion.
    News Corporation (NASDAQ: NWSA) is projected to post quarterly earnings at $0.07 per share on revenue of $1.99 billion.
    Symantec Corporation (NASDAQ: SYMC) is estimated to post quarterly earnings at $0.39 per share on revenue of $1.19 billion.
    Pilgrim's Pride Corporation (NASDAQ: PPC) is projected to post quarterly earnings at $0.54 per share on revenue of $2.65 billion.
    Hawaiian Electric Industries, Inc. (NYSE: HE) is expected to post quarterly earnings at $0.38 per share on revenue of $556.81 million.
    Air Lease Corporation (NYSE: AL) is estimated to post quarterly earnings at $1.01 per share on revenue of $383.37 million.
    Flowserve Corporation (NYSE: FLS) is expected to post quarterly earnings at $0.27 per share on revenue of $880.89 million.
    Civitas Solutions, Inc. (NYSE: CIVI) is projected to post quarterly earnings at $0.12 per share on revenue of $396.25 million.
    The Trade Desk, Inc. (NASDAQ: TTD) is estimated to post quarterly earnings at $0.1 per share on revenue of $73.23 million.
    Amdocs Limited (NYSE: DOX) is projected to post quarterly earnings at $0.95 per share on revenue of $980.50 million.
    Yelp Inc. (NYSE: YELP) is estimated to post quarterly loss at $0.04 per share on revenue of $220.14 million.
    Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) is expected to post quarterly earnings at $0.43 per share on revenue of $210.01 million.
    TiVo Corporation (NASDAQ: TIVO) is projected to post quarterly earnings at $0.37 per share on revenue of $198.62 million.
    Ritchie Bros. Auctioneers Incorporated (NYSE: RBA) is expected to post quarterly earnings at $0.17 per share on revenue of $153.87 million.
    Uniti Group Inc. (NASDAQ: UNIT) is estimated to post quarterly earnings at $0.01 per share on revenue of $247.16 million.
    Jagged Peak En

  • [By Stephan Byrd]

    Ducommun (NYSE:DCO) had its price target increased by Canaccord Genuity from $36.00 to $38.00. The firm currently has a buy rating on the stock.

    Fortress Biotech (NASDAQ:FBIO) was given a $11.00 target price by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

  • [By Ethan Ryder]

    Astronics (NASDAQ: ATRO) and Ducommun (NYSE:DCO) are both small-cap aerospace companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation and analyst recommendations.

  • [By Stephan Byrd]

    Astronics (NASDAQ: ATRO) and Ducommun (NYSE:DCO) are both small-cap aerospace companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership.

Top Warren Buffett Stocks To Buy Right Now: Chipotle Mexican Grill Inc.(CMG)

Advisors’ Opinion:

  • [By Daniel B. Kline]

    I like Chipotle Mexican Grill (NYSE:CMG), both as a business and as a consumer who enjoys tacos. The company has figured out how to create great-tasting fast food made from recognizable ingredients at a decent price.

  • [By ]

    Chipotle Mexican Grill Inc. (CMG) investors are having a very good day. 

    The stock is up 24% Thursday, April 26, following a redemptive first-quarter earnings release under brand-new CEO Brian Niccol. As of 3pm, the stock was trading at $422.70.

  • [By Jon C. Ogg]

    The long saga of the Chipotle Mexican Grill Inc. (NYSE: CMG) and its food fiascos finally may have seen its worst. In fact, an almost 20% gain in the shares after the earnings report may be signaling something even larger. Chipotle shares have now rallied a whopping 60% from the post-panic lows, and many analysts on Wall Street are still hanging on to a very cautious or negative stance.

Top Warren Buffett Stocks To Buy Right Now: Celanese Corporation(CE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Celanese (NYSE:CE)‘s stock had its “outperform” rating reiterated by Cowen in a report issued on Friday. They presently have a $125.00 price objective on the basic materials company’s stock, up from their previous price objective of $120.00. Cowen’s price objective would suggest a potential upside of 15.06% from the company’s previous close.

  • [By ]

    Eli Lilly announced in October it was conducting a strategic review for the unit.  Elanco on Monday said it has appointed Christopher Jensen, who was most recently with Celanese Corp. (CE) , as chief financial officer.

  • [By Max Byerly]

    Loomis Sayles & Co. L P purchased a new position in Celanese Co. (NYSE:CE) during the 1st quarter, HoldingsChannel reports. The firm purchased 101,256 shares of the basic materials company’s stock, valued at approximately $10,147,000.

  • [By Ethan Ryder]

    Jennison Associates LLC trimmed its stake in shares of Celanese Co. (NYSE:CE) by 0.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 527,082 shares of the basic materials company’s stock after selling 3,006 shares during the period. Jennison Associates LLC’s holdings in Celanese were worth $58,538,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Celanese (NYSE: CE) and Sealed Air (NYSE:SEE) are both basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.

Top 5 Heal Care Stocks To Invest In 2019

Public Employees Retirement Association of Colorado trimmed its position in shares of Chimera Investment Co. (NYSE:CIM) by 18.0% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 51,307 shares of the real estate investment trust’s stock after selling 11,267 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Chimera Investment were worth $893,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CIM. American Century Companies Inc. purchased a new position in Chimera Investment during the 4th quarter worth approximately $9,021,000. Two Sigma Investments LP grew its position in Chimera Investment by 916.1% during the 4th quarter. Two Sigma Investments LP now owns 420,558 shares of the real estate investment trust’s stock worth $7,772,000 after purchasing an additional 379,167 shares in the last quarter. Wells Fargo & Company MN grew its position in Chimera Investment by 19.2% during the 1st quarter. Wells Fargo & Company MN now owns 1,300,895 shares of the real estate investment trust’s stock worth $22,648,000 after purchasing an additional 209,573 shares in the last quarter. EnTrustPermal Partners Offshore LP purchased a new position in Chimera Investment during the 4th quarter worth approximately $2,938,000. Finally, Mackenzie Financial Corp grew its position in Chimera Investment by 342.5% during the 4th quarter. Mackenzie Financial Corp now owns 197,359 shares of the real estate investment trust’s stock worth $3,647,000 after purchasing an additional 152,755 shares in the last quarter. Hedge funds and other institutional investors own 51.41% of the company’s stock.

Top 5 Heal Care Stocks To Invest In 2019: Reliance Steel & Aluminum Co.(RS)

Advisors’ Opinion:

  • [By Max Byerly]

    Deroy & Devereaux Private Investment Counsel Inc. raised its holdings in Reliance Steel & Aluminum Co (NYSE:RS) by 0.4% during the 2nd quarter, HoldingsChannel reports. The fund owned 229,801 shares of the industrial products company’s stock after acquiring an additional 848 shares during the quarter. Reliance Steel & Aluminum accounts for approximately 2.1% of Deroy & Devereaux Private Investment Counsel Inc.’s investment portfolio, making the stock its 11th largest holding. Deroy & Devereaux Private Investment Counsel Inc.’s holdings in Reliance Steel & Aluminum were worth $20,117,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    American Century Companies Inc. grew its stake in Reliance Steel & Aluminum Co (NYSE:RS) by 2.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,780 shares of the industrial products company’s stock after acquiring an additional 748 shares during the period. American Century Companies Inc.’s holdings in Reliance Steel & Aluminum were worth $2,725,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    ValuEngine cut shares of Reliance Steel & Aluminum (NYSE:RS) from a buy rating to a hold rating in a research note published on Wednesday.

    Other analysts have also issued reports about the stock. KeyCorp boosted their target price on shares of Reliance Steel & Aluminum from $95.00 to $97.00 and gave the company an overweight rating in a research report on Thursday, February 15th. Zacks Investment Research lowered shares of Reliance Steel & Aluminum from a buy rating to a hold rating in a research report on Tuesday, March 13th. Cowen boosted their target price on shares of Reliance Steel & Aluminum from $101.00 to $107.00 and gave the company an outperform rating in a research report on Friday, February 16th. Goldman Sachs assumed coverage on shares of Reliance Steel & Aluminum in a research report on Tuesday, March 20th. They set a neutral rating and a $103.00 target price for the company. Finally, Bank of America set a $97.00 target price on shares of Reliance Steel & Aluminum and gave the company a buy rating in a research report on Monday, January 8th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the stock. The stock presently has an average rating of Buy and a consensus price target of $96.71.

  • [By Shane Hupp]

    Reliance Steel & Aluminum Co (NYSE:RS) hit a new 52-week high and low on Thursday . The company traded as low as $97.41 and last traded at $94.18, with a volume of 15817 shares trading hands. The stock had previously closed at $96.27.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Reliance Steel & Aluminum (RS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lee Jackson]

    Reliance Steel & Aluminum
    This is a top steel services play that the Deutsche Bank team is very positive on. Reliance Steel & Aluminum Co. (NYSE: RS) provides metals processing services and distributes a line of about 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium and specialty steel products. Its primary processing services comprise cutting, leveling, sawing, machining and electropolishing.

Top 5 Heal Care Stocks To Invest In 2019: Provident Financial Holdings, Inc.(PROV)

Advisors’ Opinion:

  • [By Max Byerly]

    News articles about Provident Financial (NASDAQ:PROV) have been trending somewhat negative this week, according to Accern. Accern identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Provident Financial earned a daily sentiment score of -0.02 on Accern’s scale. Accern also assigned news articles about the financial services provider an impact score of 45.9215692366566 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

  • [By Ethan Ryder]

    E*TRADE Financial (NASDAQ: ETFC) and Provident Financial (NASDAQ:PROV) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings and dividends.

  • [By Logan Wallace]

    Charter Financial (NASDAQ: CHFN) and Provident Financial (NASDAQ:PROV) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Top 5 Heal Care Stocks To Invest In 2019: Canadian Solar Inc.(CSIQ)

Advisors’ Opinion:

  • [By Logan Wallace]

    Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

    Get Canadian Solar alerts:

    Contrasting Canadian Solar (CSIQ) & NVE (NVEC) (americanbankingnews.com) Africa: Canadian Solar Partners With ET Energy to Build 132 MWP of Solar Projects in South Africa (allafrica.com) Canadian Solar Partners with ET Energy to Build 132 MWp of Solar Projects in South Africa (finance.yahoo.com) Canadian Solar Inc (CSIQ) Trend Analysis Report (emnnews.com) Canadian Solar Inc. (NasdaqGS:CSIQ) Quant Update and Deep Dive into the 0.023549 ROA (baycityobserver.com)

    A number of brokerages have issued reports on CSIQ. B. Riley reduced their price objective on shares of Canadian Solar from $18.00 to $17.00 and set a “hold” rating for the company in a research report on Thursday, August 23rd. Zacks Investment Research downgraded shares of Canadian Solar from a “buy” rating to a “hold” rating in a research report on Friday, August 17th. BidaskClub downgraded shares of Canadian Solar from a “buy” rating to a “hold” rating in a research report on Tuesday, August 14th. ValuEngine downgraded shares of Canadian Solar from a “sell” rating to a “strong sell” rating in a research report on Wednesday, June 20th. Finally, JPMorgan Chase & Co. raised shares of Canadian Solar from an “underweight” rating to a “neutral” rating and reduced their price objective for the stock from $17.00 to $15.00 in a research report on Thursday, June 7th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company. Canadian Solar has an average rating of “Hold” and a consensus price target of $17.67.

  • [By Motley Fool Staff]

    Canadian Solar (NASDAQ:CSIQ) Q1 2018 Earnings Conference CallMay. 16, 2018 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Paul Ausick]

    Canadian Solar Inc. (NASDAQ: CSIQ) saw an increase of 3.1% in short interest during the first two weeks of August. Some 7.6% of the total float, or 3.4 million shares, were short and days to cover fell from five to four. The company’s share price traded flat over the two-week period and shares closed Friday at $13.86, up about 3.4% for the day, in a 52-week range of $11.37 to $19.09.

  • [By Garrett Baldwin]

    By submitting your email address you will receive a free subscription to Profit Alerts and occasional special offers from Money Map Press and our affiliates. You can unsubscribe at anytime and we encourage you to read more about our privacy policy.

    The Top Stock Market Stories for Tuesday
    Hedge fund manager Carl Icahn has reversed his position on a potential deal between Cigna Inc. (NYSE: CI) and Express Scripts Holding Co. (Nasdaq: ESRX). Icahn is no longer seeking votes against the $52 billion merger. Icahn had previously written a letter that argued Cigna was paying too much for the pharmacy-benefits manager. The turning point came after proxy advisories Glass Lewis & Co. and Institutional Shareholder Services Inc. both issued their public support for the deal. Hedge fund manager David Einhorn and his firm Greenlight Capital made a major announcement this morning. The fund has cut its stake in Apple Inc. (Nasdaq: AAPL), Twitter Inc. (NYSE: TWTR), and Micron Technology Inc. (Nasdaq: MU). The updates came in a filing to the U.S. Securities and Exchange Commission and stated his firm’s positions at the end of the second quarter.
    Three Stocks to Watch Today: HD, TSLA, KO
    Shares of Home Depot Inc. (NYSE: HD) are on the move after the home retail giant reported earnings before the bell. Home Depot said earnings per share came in at $3.05 on top of $30.46 billion in revenue. The average Wall Street estimate was $2.84 on top of $29.98 billion in revenue. The firm also hiked its full-year guidance. Shares of HD stock were up 2.2% in pre-market hours. Tesla Inc. (Nasdaq: TSLA) is dominating the news as CEO Elon Musk continues to push the narrative that he will be taking his company private. According to Reuters, Musk has been speaking with Saudi Arabian financiers and others about a deal to de-list Tesla. Meanwhile, Musk is facing a lawsuit from short sellers who claim that Musk’s recent announcement of his plan on Twitter last week was part of a broader

  • [By Paul Ausick]

    Canadian Solar Inc. (NASDAQ: CSIQ) saw an increase of 10.3% in short interest during the two weeks to June 29. Some 7.2% of the total float, or 3.23 million shares, were short, and days to cover rose from one to three. The company’s share price rose by 5.9% over the two-week period, and shares closed Wednesday at $13.02, down about 1.5% for the day, in a 52-week range of $11.37 to $19.09.

Top 5 Heal Care Stocks To Invest In 2019: Gilead Sciences, Inc.(GILD)

Advisors’ Opinion:

  • [By Keith Speights]

    AbbVie’s new hepatitis C virus (HCV) drug Mavyret appears to be giving Gilead Sciences (NASDAQ:GILD) a run for its money. In the first quarter, AbbVie’s net HCV revenue came in at $919 million. That total includes both of the company’s HCV drugs, Viekira and Mavyret. But there’s virtually no question that Mavyret is contributing most of AbbVie’s HCV revenue.

  • [By Keith Speights]

    But at least three of the biotechs singled out by the FDA deserve to be on another list — investors’ buy lists. Here’s why Celgene (NASDAQ:CELG), Gilead Sciences (NASDAQ:GILD), and Jazz Pharmaceuticals (NASDAQ:JAZZ) look like great stock picks right now.

  • [By Dan Caplinger]

    The iShares biotech ETF has a structure that’s familiar to anyone who invests regularly in exchange-traded funds. The ETF tracks an index of nearly 200 biotech and pharmaceutical stocks, with roughly 80% of assets dedicated to true biotechs and the rest split evenly between pharma and life sciences equipment and services providers. Top ETF holdings Biogen (NASDAQ:BIIB), Amgen (NASDAQ:AMGN), and Gilead Sciences (NASDAQ:GILD) make up a total of roughly 25% of the fund’s assets.

  • [By Cory Renauer]

    AbbVie’s new hepatitis C virus (HCV) treatment is priced to compete with Gilead Sciences (NASDAQ:GILD) market-leading treatments and the strategy’s working. Mayvret has been a disaster for Gilead’s HCV franchise, but it did more to push AbbVie’s needle forward than any other product during the first quarter. AbbVie reported $919 billion in HCV antiviral sales, $656 million more than during the same period last year and $409 million more than during the previous quarter.

Top 5 Heal Care Stocks To Invest In 2019: CPS Technologies Corp.(CPSH)

Advisors’ Opinion:

  • [By Max Byerly]

    Media coverage about CPS Technologies (NASDAQ:CPSH) has been trending somewhat negative recently, according to Accern Sentiment. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CPS Technologies earned a media sentiment score of -0.04 on Accern’s scale. Accern also gave news headlines about the electronics maker an impact score of 47.6937573591172 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Top 10 Warren Buffett Stocks For 2019

After a promising start to 2018, major stock indexes forfeited their yearly gains over the past few weeks amid heightened concerns about a looming trade war between the U.S. and China. Now, as investors look to rebound from what has been a tough stretch for many, it could prove prudent to dig deep into the tried-and-true strategies of Wall Street’s top figures.

One of those top performers is, of course, the legendary Warren Buffett. Dubbed the “Oracle of Omaha” for his decades of success, Buffett has amassed billions of dollars through a meticulous brand of value investing that touts patience and confidence. Simply put, Buffett and his Berkshire Hathaway (BRK.B ) firm are icons of the investing world.

Berkshire Hathaway’s U.S. long stock portfolio holds positions in 45 individual stocks, with the five-largest of those positions accounting for roughly 62% of its total value. This portfolio is tracked by a large swath of investors looking to mimic the success of Berkshire’s legendary CEO.

Top 10 Warren Buffett Stocks For 2019: Fibrocell Science Inc(FCSC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Fibrocell Science (FCSC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Alexander Bird]

    We’re talking 471% potential gains…

    Penny Stock Current Share Price Last Week’s Gain
    Renren Inc. (NYSE: RENN) $2.50 158.64%
    Astrotech Corp. (Nasdaq: ASTC) $4.17 132.80%
    Xenetic Biosciences Inc. (Nasdaq: XBIO) $5.58 71.95%
    Nordic American Tanker Shipping Ltd. (NYSE: NAT) $2.73 38.43%
    United States Antimony Corp. (NYSE: UAMY) $0.49 36.47%
    Soeno Therapeutics Inc. (Nasdaq: SLNO) $2.65 33.05%
    Fibrocell Science Inc. (Nasdaq: FCSC) $3.16 31.36%
    Teekay Tankers Ltd. (NYSE: TNK) $1.30 29.70%
    Neovasc Inc. (Nasdaq: NVCN) $0.04 27.30%
    Actinium Pharmaceuticals Inc. (OTCMKTS: ATNM) $0.24 25.98%

    While the gains of last week’s top penny stocks are exciting, investors who know where to look can unlock even bigger gains…

  • [By Stephan Byrd]

    Here are some of the news articles that may have effected Accern’s rankings:

    Get Fibrocell alerts:

    Year-to-date (YTD) in the Spotlight Fibrocell Science, Inc. (NASDAQ:FCSC), eMagin Corporation (NYSE:EMAN … (stocksnewspoint.com) Have an eye on: Fibrocell Science, Inc. (NASDAQ:FCSC), Kelso Technologies Inc. (NYSE:KIQ), Siebert Financial Corp … (journalfinance.net) Fibrocell Science (FCSC) Sees Hammer Chart Pattern: Time to Buy? (finance.yahoo.com) Chester County gene therapy company completes $6M stock sale (finance.yahoo.com) Wining Three Stocks: MasTec, Inc. (NYSE:MTZ), Fibrocell Science, Inc. (NASDAQ:FCSC), Volt Information Sciences … (thestreetpoint.com)

    Shares of FCSC traded down $0.16 during mid-day trading on Friday, hitting $2.40. 283,121 shares of the company’s stock were exchanged, compared to its average volume of 206,910. The stock has a market capitalization of $14.57 million, a PE ratio of -0.29 and a beta of 0.45. Fibrocell has a fifty-two week low of $2.21 and a fifty-two week high of $23.20.

  • [By Lisa Levin]

    Shares of Fibrocell Science, Inc. (NASDAQ: FCSC) were down 10 percent to $2.58. Fibrocell reported a $6.0 million registered direct offering priced at-the-market.

Top 10 Warren Buffett Stocks For 2019: Coca-Cola Enterprises, Inc.(CCE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Neuberger Berman Group LLC raised its holdings in Coca-Cola European Partners PLC (NYSE:CCE) by 35.5% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 31,270 shares of the company’s stock after acquiring an additional 8,187 shares during the quarter. Neuberger Berman Group LLC’s holdings in Coca-Cola European Partners were worth $1,326,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Aristotle Capital Management LLC raised its holdings in shares of Coca-Cola European Partners PLC (NYSE:CCE) by 9.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 363,371 shares of the company’s stock after purchasing an additional 30,783 shares during the period. Aristotle Capital Management LLC owned approximately 0.08% of Coca-Cola European Partners worth $15,138,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Coca-Cola European Partners (CCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    These are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

    Get Coca-Cola European Partners alerts:

    Coca-Cola European Partners (CCE) Lowered to “Sell” at ValuEngine (americanbankingnews.com) $3.69 Billion in Sales Expected for Coca-Cola European Partners (CCE) This Quarter (americanbankingnews.com) Zacks: Analysts Anticipate Coca-Cola European Partners (CCE) to Post $0.81 EPS (americanbankingnews.com) Critical Contrast: Coca-Cola European Partners (CCE) and Coca-Cola Bottling Co. Consolidated (COKE) (americanbankingnews.com) Coca-Cola European Partners (CCE) Sees Large Drop in Short Interest (americanbankingnews.com)

    Shares of CCE traded down $0.51 during trading hours on Monday, hitting $37.88. The stock had a trading volume of 705,278 shares, compared to its average volume of 1,496,087. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.03 and a quick ratio of 0.79. The company has a market cap of $18.60 billion, a PE ratio of 15.85, a P/E/G ratio of 1.93 and a beta of 0.76. Coca-Cola European Partners has a 1-year low of $36.17 and a 1-year high of $44.75.

Top 10 Warren Buffett Stocks For 2019: Gilead Sciences, Inc.(GILD)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer, Rich Smith, and Sean Williams]

    Not many companies have monopolies, though some get pretty close. That list includes Russian telecom giantMobile TeleSystems (NYSE:MBT), biotech playerGilead Sciences, Inc.(NASDAQ:GILD), and tobacco makerAltria Group, Inc. (NYSE:MO). Each one has a slightly different virtual monopoly and they clearly have vastly different businesses. But if you are looking for income from seriously entrenched industry players, you’ll want to get to know this trio of high-yielders.

  • [By Cory Renauer]

    AbbVie’s new hepatitis C virus (HCV) treatment is priced to compete withGilead Sciences (NASDAQ:GILD) market-leading treatments and the strategy’s working. Mayvret has been a disaster for Gilead’s HCV franchise, but it did more to push AbbVie’s needle forward than any other product during the first quarter. AbbVie reported $919 billion in HCV antiviral sales, $656 million more than during the same period last year and $409 million more than during the previous quarter.

  • [By Chris Lange]

    Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest increase to 18.14 million shares from 16.28 million in the previous period. Shares were trading at $71.83 in a 52-week range of $63.76 to $89.54.

  • [By Chris Lange]

    Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest increase slightly to 16.28 million shares from 16.13 million in the previous period. Shares were trading at $67.85, in a 52-week range of $63.76 to $89.54.

  • [By Keith Speights]

    But at least three of the biotechs singled out by the FDA deserve to be on another list — investors’ buy lists. Here’s why Celgene (NASDAQ:CELG), Gilead Sciences (NASDAQ:GILD), and Jazz Pharmaceuticals (NASDAQ:JAZZ) look like great stock picks right now.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Gilead Sciences (GILD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Warren Buffett Stocks For 2019: iShares Morningstar Large-Cap Growth (JKE)

Advisors’ Opinion:

  • [By Joseph Griffin]

    iShares Morningstar Large Growth (NYSEARCA:JKE) declared a quarterly dividend on Tuesday, June 26th, Wall Street Journal reports. Investors of record on Wednesday, June 27th will be paid a dividend of 0.3796 per share on Monday, July 2nd. This represents a $1.52 annualized dividend and a yield of 0.87%. The ex-dividend date is Tuesday, June 26th. This is a boost from iShares Morningstar Large Growth’s previous quarterly dividend of $0.34.

Top 10 Warren Buffett Stocks For 2019: Iridium Communications Inc(IRDM)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Ground-based wireless communications networks have transformed the way that billions of people across the globe communicate. For the locations where traditional wireless networks either haven’t yet reached or have decided aren’t feasible for ground-based stations, Iridium Communications (NASDAQ:IRDM) hopes that its extensive and growing satellite communications network will be the go-to solution for users who need reliable coverage under challenging circumstances.

  • [By Max Byerly]

    Iridium Communications (NASDAQ: IRDM) and Inseego (NASDAQ:INSG) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, risk and profitability.

  • [By Daniel Sparks]

    Shares of satellite communications company Iridium Communications(NASDAQ:IRDM) jumped as much as 16.4% on Friday,following the announcement of a partnership between Iridium and in-flight broadband connectivity and wireless entertainment services company Gogo(NASDAQ:GOGO). At the time of this writing, Iridium stock is up 11.3% on Friday.

  • [By Ethan Ryder]

    Iridium Communications (NASDAQ:IRDM) last announced its earnings results on Thursday, April 26th. The technology company reported $0.07 EPS for the quarter, topping the consensus estimate of $0.04 by $0.03. The business had revenue of $119.10 million during the quarter, compared to the consensus estimate of $111.60 million. Iridium Communications had a net margin of 44.81% and a return on equity of 5.19%. Iridium Communications’s revenue was up 14.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.30 EPS. sell-side analysts forecast that Iridium Communications Inc will post 0.11 EPS for the current year.

  • [By Nicholas Rossolillo]

    Shares of satellite communications provider Iridium Communications (NASDAQ:IRDM) rocketed 40% higher in the last two weeks. The company has had good press since its first-quarter 2018 report at the end of April, making advancements with its new network and getting some help from Wall Street analysts. While there was good reason to feel optimistic, expectations might need to be tempered after the stock pop.

Top 10 Warren Buffett Stocks For 2019: Euro Tech Holdings Company Limited(CLWT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Euro Tech Holdings Company Limited (NASDAQ: CLWT) was down, falling around 7 percent to $3.745 after dropping 30.26 percent on Friday.

    Commodities

  • [By Lisa Levin]

    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares shot up 35 percent to $5.20 after the company declared a $0.70 per share special dividend.

  • [By Lisa Levin]

    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares shot up 93 percent to $6.16 after reporting 2017 year-end results.

    Shares of SORL Auto Parts, Inc. (NASDAQ: SORL) got a boost, shooting up 13 percent to $5.90 after reporting upbeat Q1 results.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 18.2 percent to $4.55 in pre-market trading after the company declared a $0.70 per share special dividend.
    Co-Diagnostics, Inc. (NASDAQ: CODX) rose 11.7 percent to $3.24 in pre-market trading after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Abercrombie & Fitch Co. (NYSE: ANF) shares rose 8.6 percent to $25.95 in pre-market trading after the company posted upbeat Q1 results.
    Zuora, Inc. (NYSE: ZUO) shares rose 8 percent to $23.95 in pre-market trading after the company reported upbeat Q1 earnings and issued strong outlook.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares rose 7.8 percent to $113.25 in pre-market trading after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    OPKO Health, Inc. (NYSE: OPK) rose 5.7 percent to $4.10 in pre-market trading.
    Lannett Company, Inc. (NYSE: LCI) rose 5.5 percent to $17.45 in pre-market trading following the FDA approval for Levofloxacin Oral Solution.
    Eversource Energy (NYSE: ES) shares rose 5 percent to $59.8 in pre-market trading.
    VMware, Inc. (NYSE: VMW) rose 4.6 percent to $143.74 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Thursday.
    Energy Transfer Partners, L.P. (NYSE: ETP) rose 4.3 percent to $19.80 in pre-market trading after the company reported the Federal Energy Regulatory Commission approval to place Rover pipeline’s full Mainline B into service.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 4.3 percent to $7.73 in pre-market trading after declining 4.26 percent on Thursday.
    Curis, Inc. (NASDAQ: CRIS) rose 4.3 percent to $2.90 in pre-market trading after jumping 21.93 percent on Thursday.
    Sasol Limited (NYSE: SSL) rose 4.2 percent to $37.91 in pre-market trading.
    Nucor Corporatio
  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
    Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
    Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
    RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
    Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
    Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
    Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
    CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering

  • [By Lisa Levin]

    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares shot up 40 percent to $5.3750 after the company declared a $0.70 per share special dividend.

Top 10 Warren Buffett Stocks For 2019: Beneficial Mutual Bancorp Inc.(BNCL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Media coverage about Beneficial Bancorp (NASDAQ:BNCL) has trended positive recently, according to Accern. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Beneficial Bancorp earned a news impact score of 0.38 on Accern’s scale. Accern also gave media headlines about the bank an impact score of 45.8699493506664 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Ethan Ryder]

    BidaskClub upgraded shares of Beneficial Bancorp (NASDAQ:BNCL) from a sell rating to a hold rating in a report released on Tuesday morning.

    Shares of Beneficial Bancorp opened at $16.35 on Tuesday, MarketBeat.com reports. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $1.23 billion, a P/E ratio of 31.44 and a beta of 0.55. Beneficial Bancorp has a fifty-two week low of $14.40 and a fifty-two week high of $17.50.

  • [By Logan Wallace]

    Beneficial Bancorp (NASDAQ: BNCL) and Home Bancorp (NASDAQ:HBCP) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends and valuation.

  • [By Joseph Griffin]

    Beneficial Bancorp Inc (NASDAQ:BNCL) Director Thomas J. Lewis sold 973 shares of the company’s stock in a transaction dated Wednesday, May 30th. The stock was sold at an average price of $16.50, for a total value of $16,054.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Top 10 Warren Buffett Stocks For 2019: TrueBlue Inc.(TBI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    American Century Companies Inc. grew its holdings in shares of Trueblue Inc (NYSE:TBI) by 24.4% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 95,307 shares of the business services provider’s stock after purchasing an additional 18,680 shares during the period. American Century Companies Inc. owned approximately 0.23% of Trueblue worth $2,468,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Trueblue (NYSE: TBI) is one of 23 public companies in the “Help supply services” industry, but how does it contrast to its rivals? We will compare Trueblue to similar businesses based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, earnings and risk.

  • [By Joseph Griffin]

    Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.

  • [By Stephan Byrd]

    Russell Investments Group Ltd. grew its stake in Trueblue Inc (NYSE:TBI) by 21.2% during the first quarter, HoldingsChannel reports. The fund owned 137,178 shares of the business services provider’s stock after purchasing an additional 23,951 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trueblue were worth $3,553,000 at the end of the most recent quarter.

Top 10 Warren Buffett Stocks For 2019: Hexcel Corporation(HXL)

Advisors’ Opinion:

  • [By Max Byerly]

    Earnest Partners LLC increased its position in Hexcel Co. (NYSE:HXL) by 2.0% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,810,533 shares of the aerospace company’s stock after buying an additional 54,698 shares during the quarter. Hexcel accounts for 1.7% of Earnest Partners LLC’s portfolio, making the stock its 3rd largest position. Earnest Partners LLC’s holdings in Hexcel were worth $181,532,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Hexcel Co. (NYSE:HXL) has earned a consensus rating of “Hold” from the fourteen analysts that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $71.27.

  • [By Logan Wallace]

    Xact Kapitalforvaltning AB lifted its position in shares of Hexcel Co. (NYSE:HXL) by 51.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,174 shares of the aerospace company’s stock after acquiring an additional 3,800 shares during the quarter. Xact Kapitalforvaltning AB’s holdings in Hexcel were worth $722,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Trillium Asset Management LLC lessened its holdings in Hexcel (NYSE:HXL) by 12.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 331,664 shares of the aerospace company’s stock after selling 47,089 shares during the quarter. Hexcel makes up approximately 1.2% of Trillium Asset Management LLC’s investment portfolio, making the stock its 19th largest position. Trillium Asset Management LLC owned 0.37% of Hexcel worth $21,422,000 at the end of the most recent quarter.

  • [By Lee Samaha]

    Advanced materials are loosely defined as those designed with enhanced properties that improve on traditionally used materials. A broader definition includes materials seeing increased demand due to advanced technologies. For example, if you want to reduce the weight of aircraft (while also increasing strength) then Hexcel Corp. (NYSE: HXL) advanced composites are going to come in handy. Similarly, if you believe in the future of electric vehicles then the lithium produced byAlbemarle Corp. (NYSE: ALB) (used in batteries) will surely come into high demand in the future. Moreover, if you want to invest in companies that provide technology to materials processors then high-performance laser manufacturer IPG Photonics Corp. (NASDAQ: IPGP) is well worth a look. Here’s the investment case for all three.

Top 10 Warren Buffett Stocks For 2019: CLP Holdings Ltd (2)

Advisors’ Opinion:

  • [By ]

    (1) Cash flow adjusted by working capital and, in the case of Aramco, $21.4 billion owed to the company from the government (2) Production for all companies is the annual average for 2016, the most recent figures available for Aramco

  • [By ]

    Long-Short sub-strategy funds gained 1.24 percent in May, underperforming the S&P 500 by 117 basis points.

    NOTE: Go to HFND and select option 3 to see the Bloomberg Hedge Fund Database Snapshot for more details on hedge fund performanceNOTE: See HFS to screen for specific hedge fundsNOTE: All data are total return including reinvested dividends. May data are the most recent available. June returns become available around July 12.NOTE: “Equity Hedge” refers to a Bloomberg-created term for strategies where the largest subset of funds is L/S Equity and Long-Biased hedge fundsRELATED: Here are how some hedge funds performed last monthJune 11: Hedge Fund With 69% Return Sees More to Come From Oil RecoveryJune 8: Macro Hedge Funds Cashed In on Mess From Italy, Trade Wars (2)June 7: BlackRock’s Biggest Hedge Fund Bleeds Talent as Deputy CIOs Exit

    — With assistance by Brian Pennisi

Hot Undervalued Stocks To Own For 2019

Generating alpha in today’s market is quite challenging. With the speed that information is disseminated it has become difficult to find undervalued opportunities to achieve outsized returns; once news becomes public, a stock quickly is re-priced to reflect this new information. In today’s highly competitive environment, the way to beat the market is to put disparate pieces of information together to paint a picture of what might be coming down the pipe.

Prior Examples

Glu Mobile (GLUU) Example

My article on GLUU provides a good example of how I pieced together disparate pieces of information to generate alpha. In my article entitled Glu Mobile: A Stock Darling for 2017, I outlined several factors that were contributing to the stock trading at a significantly undervalued level. These factors included: tax loss harvesting, investors not pricing in the value of GLUU’s evergreen strategy, GLUU’s short interest level, and strong insider buying.

Each of these factors in isolation didn’t provide a compelling narrative as to GLUU’s potential, but by putting them all together one is able to see why the stock might be temporarily trading at a depressed level. At the time of publishing, GLUU was trading at $1.94 per share and I suggested investors take their profits in August at $3.15 per share–although this was a bit too early since the stock is currently trading at $5.76 per share. Nonetheless, this anecdote provides evidence about how it is still possible to do a deep dive on a company and glean insight into why the market may be myopically viewing a stock.

Hot Undervalued Stocks To Own For 2019: RAIT Financial Trust(RAS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    RAIT Financial Trust (NYSE:RAS) will announce its earnings results before the market opens on Wednesday, May 23rd. Analysts expect the company to announce earnings of $0.21 per share for the quarter.

Hot Undervalued Stocks To Own For 2019: 1st Source Corporation(SRCE)

Advisors’ Opinion:

  • [By ]

    Currently, I like People’s Utah Bancorp (Nasdaq: PUB), 1st Source Corporation (Nasdaq: SRCE), and East West Bancorp (Nasdaq: EWBC) as stocks likely to benefit in the small/regional sector.

  • [By Max Byerly]

    1st Source (NASDAQ:SRCE)’s share price hit a new 52-week high and low during mid-day trading on Thursday . The stock traded as low as $56.13 and last traded at $55.94, with a volume of 100 shares changing hands. The stock had previously closed at $55.94.

  • [By Max Byerly]

    1st Source Co. (NASDAQ:SRCE) has been assigned a consensus rating of “Hold” from the six analysts that are presently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month target price among analysts that have covered the stock in the last year is $55.00.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on 1st Source (SRCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Undervalued Stocks To Own For 2019: Gilead Sciences, Inc.(GILD)

Advisors’ Opinion:

  • [By Logan Wallace]

    KBC Group NV trimmed its stake in Gilead Sciences, Inc. (NASDAQ:GILD) by 10.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 227,921 shares of the biopharmaceutical company’s stock after selling 27,406 shares during the period. KBC Group NV’s holdings in Gilead Sciences were worth $17,183,000 at the end of the most recent quarter.

  • [By Todd Campbell]

    Sangamo Therapeutics has alsoinked a collaborationwith Gilead Sciences (NASDAQ:GILD)to work on ZFN approaches that may improve cancer treatment. As part of that deal, Sangamo received an upfront payment of $150 million from Gilead Sciences and it could receive up to $3.01 billion in potential milestones. If any therapies from this collaboration win approval, then Sangamo will receive tiered royalties on future sales.

  • [By Cory Renauer]

    Biotech traders get heaps of attention, but buying promising young drugmakers and holding them for the long term is a far easier way to get rich. Case in point: Spreading $10,000 evenly among shares of Biogen Inc. (NASDAQ:BIIB),Celgene Corporation (NASDAQ:CELG), andGilead Sciences Inc.(NASDAQ:GILD) around this time in 1998 would have made you a millionaire already.

  • [By Matthew Cochrane]

    A value trap is a stock that appears to be cheap but, in reality, is not because of deteriorating business conditions. Examples of traps include pharmaceutical companies with a valuable patent set to expire, cyclical stocks at the peak of the cycle, or tech stocks in the midst of having their expertise being commoditized away. Unfortunately, this is a pitfall I have firsthand experience with. In early 2016, I bought shares of Gilead Sciences, Inc. (NASDAQ: GILD) for just under $93. At the time, Gilead’s trailing twelve months EPS was $11.74 giving it what I thought was a dirt cheap P/E ratio of 7.9 — I thought shares were a steal.

Hot Undervalued Stocks To Own For 2019: Student Transportation Inc(STB)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Student Transportation (STB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    That was certainly the case with Student Transportation (NYSE: STB). My former High-Yield Investing holding was trading at $6.00 per share at the closing bell on February 27. The next morning, it opened near $7.50 following a surprise takeover offer from a privately held Canadian company — giving us a nice 25% gain overnight.

  • [By ]

    One of the main goals of my premium newsletter High-Yield Investing is stability. I like industries that don’t go through unpredictable hot and cold cycles. Student Transportation (NYSE: STB) is a textbook example.

Hot Undervalued Stocks To Own For 2019: CSP Inc.(CSPI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Headlines about CSP (NASDAQ:CSPI) have been trending somewhat positive this week, according to Accern. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CSP earned a news sentiment score of 0.07 on Accern’s scale. Accern also gave headlines about the information technology services provider an impact score of 44.9831568716707 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.